期刊文献+

人乳头瘤病毒16型E7基因的原核克隆与表达

Cloning and expression of HPV16 E7 gene
下载PDF
导出
摘要 目的:研究人乳头瘤病毒(Human papillomavirus HPV)16型E7在原核表达系统中的表达情况和活性,为制备HPV16型E7蛋白疫苗奠定实验基础。方法:通过聚合酶联反应(Polymerase Chain Reaction,PCR)从HPV16 DNA阳性的宫颈癌组织中扩增HPV16 E7全长基因,进一步将其克隆入原核表达载体pET32a(+),并构建重组质粒pET32a(+)/HPV16E7,经测序鉴定后转化大肠杆菌BL21(DE3),经异丙基硫代-β-D-半乳糖苷(IPTG)诱导表达的融合蛋白,用镍螯合亲和层析胶体(Ni-NTA Agarose)纯化,十二烷基磺酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)、蛋白质印迹法(Western blot,WB)分析鉴定。结果:测序证明成功构建重组质粒pET32a/HPV16E7,IPTG诱导下HPV16E7融合蛋白在大肠杆菌中得到高效表达,重组蛋白的表达量占菌体总蛋白的16%,蛋白质印迹鉴定重组E7蛋白与表达载体的标签蛋白形成相对分子质量约30×103的可溶性融合蛋白。结论:重组质粒pET32a/HPV16E7在大肠杆菌BL21中高效表达目的蛋白。 Objective:To study the expression and activity of the gene E7 protein of human papillomavirus in the expression system of the prokaryon and built an experimental foundation for preparing the E7 recombinant protein. Methods:HPV16E7 gene amplified by PCR was cloned into the expression vector pET32a to form recombinant plasmid pET32a/HPV 16ET,then transformed into E. coli BL21. The pET32a/HPV16 E7 fusion protein was induced by IPTG and purified with Ni-NTA gel chromatography column. The protein was verified with SDS-PAGE and Western blot. Results:The recombinan plasmid was identified and confirmed with double enzymes digestion and sequencing. It was suggested that the recombinant E7 protein was expressed with SDS-PAGE and western blot, and a molecular weight was about 30 × 10^3. The fusion protein was about 16% of the total bacterial protein. Conclusions:Highly expressed E7 protein of HPV16 is obtained.
出处 《温州医学院学报》 CAS 2007年第2期104-106,共3页 Journal of Wenzhou Medical College
基金 浙江省自然科学基金资助项目(Y204054)。
关键词 人乳头瘤病毒16 E7蛋白 原核表达 宫颈癌 human pappilomavirus type16 E7 recombinant protein prokaryotic expression cervix cancer
  • 相关文献

参考文献8

  • 1zur Hausen H.Papillomaviruses and cancer:from basic studies to clinical application[J].Nat Rev Cancer,2002,2(5):342-350.
  • 2Hopfl R,Heim K,Christensen N,et al.Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7[J].Lancet,2000,356(9246):1985-19856.
  • 3Frazer IH,Quinn M,Nicklin JL,et al.Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia[J].Vaccine,2004,23(2):172-181.
  • 4Xinlai Qian,Yuanzhi Lu,Qiao Liu,et al.Prophylactic,therapeutic and anti-metastatic effects of anHPV-16 mE6△/mE7/TBhsp70 △ fusion protein vaccine in an animal model[J].Immunology Letters,2006,102(2):191-201.
  • 5Nakagawa M,Kim KH,Moscicki AB,et al.Different methods of identifying new antigenic epitopes of human papillomavirus type 16 E6 and E7 proteins[J].Clin Diagn Lab Immunol,2004,11(5):889-896.
  • 6Park DS,Selvey LA,Kesall SR,et al.Human papillomavirus type16E6,E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses[J].J Virol Methods,1993,45(3):303-318.
  • 7Braspenning L,Manetti R,Zumbach K,et al.A general purification protocol for E7 proteins from "high-and lowrisk" human papillomavirus types expressed in the yeast Schizosaccharomyces pombe[J].Protein Expr Purif,1997,10 (2):192-201.
  • 8伍欣星,赵,丁晓华,邱小萍,谭云,戴天力,赵文先.人乳头瘤病毒(地方株)16型E7蛋白的抗原性和免疫原性研究[J].免疫学杂志,1998,14(2):79-81. 被引量:3

二级参考文献3

  • 1伍欣星,中华微生物学和免疫学杂志,1996年,16卷,395页
  • 2苏应斌,国外医学.分子生物学分册,1995年,17卷,62页
  • 3金冬雁(译),分子克隆实验指南,1992年

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部